Elizabeth M. Davis

4.6k total citations · 1 hit paper
64 papers, 3.3k citations indexed

About

Elizabeth M. Davis is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Elizabeth M. Davis has authored 64 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 22 papers in Hematology and 9 papers in Genetics. Recurrent topics in Elizabeth M. Davis's work include Acute Myeloid Leukemia Research (20 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Retinoids in leukemia and cellular processes (6 papers). Elizabeth M. Davis is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Retinoids in leukemia and cellular processes (6 papers). Elizabeth M. Davis collaborates with scholars based in United States, United Kingdom and Japan. Elizabeth M. Davis's co-authors include Michelle M. Le Beau, James P. Carney, William F. Morgan, Lara G. Hays, John R. Yates, Michelle Le Beau, Richard S. Maser, Heidi Olivares, John H.J. Petrini and Rafael Espinosa and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Elizabeth M. Davis

63 papers receiving 3.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The hMre11/hRad50 Protein Complex and Nijmegen Breakage Syndrome: Linkage of Double-Strand Break Repair to the Cellular DNA Damage Response

1998 981 citations Elizabeth M. Davis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth M. Davis United States	30	2.2k	715	584	508	416	64	3.3k
Marianne G. Rots Netherlands	36	2.8k 1.3×	219 0.3×	587 1.0×	371 0.7×	602 1.4×	111	4.0k
Ramya Kollipara United States	16	3.3k 1.5×	392 0.5×	517 0.9×	553 1.1×	211 0.5×	50	5.0k
David Millar United Kingdom	24	3.1k 1.4×	809 1.1×	195 0.3×	355 0.7×	992 2.4×	60	4.8k
Christine Richardson United States	38	4.1k 1.9×	270 0.4×	649 1.1×	564 1.1×	599 1.4×	95	5.4k
Michael Schuster United States	27	1.6k 0.7×	871 1.2×	676 1.2×	223 0.4×	192 0.5×	76	3.0k
Laura P. O’Neill United Kingdom	33	3.4k 1.5×	291 0.4×	215 0.4×	408 0.8×	1.1k 2.6×	53	4.2k
Najah T. Nassif Australia	28	2.0k 0.9×	305 0.4×	541 0.9×	306 0.6×	403 1.0×	78	3.1k
Gordon Strathdee United Kingdom	28	2.5k 1.1×	159 0.2×	463 0.8×	605 1.2×	471 1.1×	50	3.1k
Paul A. Cloos Denmark	29	4.9k 2.2×	175 0.2×	609 1.0×	570 1.1×	854 2.1×	46	6.1k
Alessandra Carè Italy	35	2.5k 1.1×	323 0.5×	605 1.0×	1.1k 2.2×	329 0.8×	95	4.1k

Countries citing papers authored by Elizabeth M. Davis

Since Specialization

Citations

This map shows the geographic impact of Elizabeth M. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth M. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth M. Davis more than expected).

Fields of papers citing papers by Elizabeth M. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth M. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth M. Davis. The network helps show where Elizabeth M. Davis may publish in the future.

Co-authorship network of co-authors of Elizabeth M. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth M. Davis. A scholar is included among the top collaborators of Elizabeth M. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth M. Davis. Elizabeth M. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carnino, Jonathan M., Megan Willis, Michael B. Cohen, et al.. (2024). Assessing ChatGPT’s Responses to Otolaryngology Patient Questions. Annals of Otology Rhinology & Laryngology. 133(7). 658–664. 7 indexed citations

Stoddart, Angela, Anthony A. Fernald, Elizabeth M. Davis, Megan E. McNerney, & Michelle M. Le Beau. (2022). EGR1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy. Experimental Hematology. 115. 54–67. 4 indexed citations

Dyke, Miriam E. Van, Maria C.B. Mendoza, Wen Li, et al.. (2021). Racial and Ethnic Disparities in COVID-19 Incidence by Age, Sex, and Period Among Persons Aged <25 Years — 16 U.S. Jurisdictions, January 1–December 31, 2020. MMWR Morbidity and Mortality Weekly Report. 70(11). 382–388. 72 indexed citations

Stoddart, Angela, Jianghong Wang, Anthony A. Fernald, et al.. (2020). Cytotoxic Therapy–Induced Effects on Both Hematopoietic and Marrow Stromal Cells Promotes Therapy-Related Myeloid Neoplasms. Blood Cancer Discovery. 1(1). 32–47. 22 indexed citations

Vasanthakumar, Aparna, Masha Kocherginsky, Elizabeth M. Davis, et al.. (2013). Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis. Blood. 121(11). 2059–2063. 36 indexed citations

Bartom, Elizabeth T., Megan E. McNerney, Angela Stoddart, et al.. (2011). GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS. SHILAP Revista de lepidopterología. 2 indexed citations

Stoddart, Angela, Megan E. McNerney, Elizabeth T. Bartom, et al.. (2011). GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS. SHILAP Revista de lepidopterología. 3(1). e2011019–e2011019. 12 indexed citations

Shah, Mrinal Y., Aparna Vasanthakumar, Natalie Y. Barnes, et al.. (2010). DNMT3B7, a Truncated DNMT3B Isoform Expressed in Human Tumors, Disrupts Embryonic Development and Accelerates Lymphomagenesis. Cancer Research. 70(14). 5840–5850. 52 indexed citations

Jiang, Yanwen, Isabelle Lucas, David J. Young, et al.. (2009). Common fragile sites are characterized by histone hypoacetylation. Human Molecular Genetics. 18(23). 4501–4512. 47 indexed citations

10.

Storlie, Eric, Robert J. Ihry, Leslie M. Baehr, et al.. (2008). Genomic regions influencing gene expression of the HMW glutenins in wheat. Theoretical and Applied Genetics. 118(2). 295–303. 8 indexed citations

11.

Davis, Elizabeth M., et al.. (2007). Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins. Oncogene. 26(38). 5553–5563. 113 indexed citations

12.

Espinosa, Rafael, et al.. (2002). Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.. PubMed. 62(12). 3477–84. 53 indexed citations

13.

Korthäuer, Ulf, Wolfgang Nagel, Elizabeth M. Davis, et al.. (2000). Anergic T Lymphocytes Selectively Express an Integrin Regulatory Protein of the Cytohesin Family. The Journal of Immunology. 164(1). 308–318. 29 indexed citations

14.

Eisenbart, James, et al.. (2000). Refinement of the Smallest Commonly Deleted Segment of Chromosome 20 in Malignant Myeloid Diseases and Development of a PAC-Based Physical and Transcription Map. Genomics. 67(1). 28–39. 29 indexed citations

15.

Spielberger, Ricardo, Maya Thangavelu, Nanding Zhao, et al.. (1997). dic(5;17): A recurring abnormality in malignant myeloid disorders associated with mutations ofTP53. Genes Chromosomes and Cancer. 20(3). 282–291. 50 indexed citations

16.

Chekmareva, Marina, Courtney M.P. Hollowell, Robert C. Smith, et al.. (1997). Localization of prostate cancer metastasis-suppressor activity on human chromosome 17. The Prostate. 33(4). 271–280. 35 indexed citations

17.

Lehto, Markku, Xiangya Huang, Elizabeth M. Davis, et al.. (1995). Human hexokinase II gene: exon-intron organization, mutation screening in NIDDM, and its relationship to muscle hexokinase activity. Diabetologia. 38(12). 1466–1474. 12 indexed citations

18.

Thangavelu, Maya, Mitchell A. Bitter, Richard A. Larson, et al.. (1989). der(5)t(5;7)(q11.2;p11.2): A new recurring abnormality in malignant myeloid disorders. Cancer Genetics and Cytogenetics. 37(1). 1–8. 10 indexed citations

19.

Davis, Elizabeth M.. (1984). Rape Shield Statutes: Legislative Responses to Probative Dangers. Open Scholarship Institutional Repository (Washington University in St. Louis). 27(1). 271–294. 1 indexed citations

20.

Davis, Elizabeth M., et al.. (1966). The Effect of Radioprotective Compounds on the Incorporation of Tritiated Thymidine into Mammalian Cells. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 10(4). 343–352. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact